Involvement of multiple genetic loci in Staphylococcus aureus teicoplanin resistance by Bischoff, M et al.
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2001
Involvement of multiple genetic loci in Staphylococcus aureus teicoplanin
resistance
Bischoff, M; Roos, M; Putnik, J; Wada, A; Glanzmann, P; Giachino, P; Vaudaux, P; Berger-Bächi, B
Abstract: Teicoplanin resistance was transformed from a teicoplanin-resistant Staphylococcus aureus
into the susceptible strain BB255 to give strain BB938. The cell wall composition, amidation of the
iD-glutamate, and peptide crosslinking were identical in BB938 as in BB255 except for a 60% increased
length of the glycan chain. Transductional crosses revealed that at least two distinct loci contributed in
a cumulative fashion to teicoplanin resistance. One of these loci correlated with a mutation inactivating
the anti-sigma factor RsbW. This mutation must have occurred during transformation and selection for
teicoplanin resistance in BB938. Genetic manipulations involving the sigB operon showed that transcrip-
tion factor SigB contributed to decreased teicoplanin susceptibility.
DOI: https://doi.org/10.1111/j.1574-6968.2001.tb09449.x
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: https://doi.org/10.5167/uzh-61954
Journal Article
Published Version
Originally published at:
Bischoff, M; Roos, M; Putnik, J; Wada, A; Glanzmann, P; Giachino, P; Vaudaux, P; Berger-Bächi, B
(2001). Involvement of multiple genetic loci in Staphylococcus aureus teicoplanin resistance. FEMS
Microbiology Letters, 194(1):77-82.
DOI: https://doi.org/10.1111/j.1574-6968.2001.tb09449.x
Involvement of multiple genetic loci in Staphylococcus aureus
teicoplanin resistance
Markus Bischo¡ a, Martin Roos b, Jasmina Putnik a, Akihito Wada a,
Philipp Glanzmann a, Philipp Giachino a, Pierre Vaudaux c, B. Berger-Ba«chi a;*
a Institute of Medical Microbiology, University of Zu«rich, Gloriastr. 32, Postfach, CH-8028 Zu«rich, Switzerland
b Robert Koch Institut, Nordufer 20, D-13353 Berlin, Germany
c Division of Infectious Diseases, University Hospital Geneva, CH-1211 Geneva, Switzerland
Received 25 August 2000; received in revised form 19 October 2000; accepted 27 October 2000
Abstract
Teicoplanin resistance was transformed from a teicoplanin-resistant Staphylococcus aureus into the susceptible strain BB255 to give strain
BB938. The cell wall composition, amidation of the iD-glutamate, and peptide crosslinking were identical in BB938 as in BB255 except for a
60% increased length of the glycan chain. Transductional crosses revealed that at least two distinct loci contributed in a cumulative fashion
to teicoplanin resistance. One of these loci correlated with a mutation inactivating the anti-sigma factor RsbW. This mutation must have
occurred during transformation and selection for teicoplanin resistance in BB938. Genetic manipulations involving the sigB operon showed
that transcription factor SigB contributed to decreased teicoplanin susceptibility. ß 2001 Federation of European Microbiological
Societies. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Vancomycin and teicoplanin are the most commonly
used drugs for the therapy of multiresistant, methicillin-
resistant Staphylococcus aureus. They act by binding to the
D-Ala^D-Ala termini of the nascent lipid II-linked murein
precursor thereby inhibiting the polymerization of the gly-
can chains and the crosslinking of the peptide moiety of
the peptidoglycan. Glycopeptide resistance in S. aureus
can be produced through mutation and selection on ex-
posure to glycopeptides. Teicoplanin resistance is more
readily acquired than vancomycin resistance and emer-
gence of teicoplanin resistance may be a prelude to emerg-
ing vancomycin resistance (reviewed in [1]). Among staph-
ylococci, coagulase negative staphylococci became the ¢rst
to have developed teicoplanin resistance. The ¢rst teico-
planin-resistant clinical S. aureus isolates emerging under
teicoplanin therapy were described in 1990 [2]. Teicoplanin
resistance was accompanied by an increase in the amount
PBP2 and the production of a 35-kDa membrane protein
[3]. A Tn551 insertion in the SmaI-I fragment of the chro-
mosome resulted in lowered PBP2 and 35-kDa membrane
protein and increased sensitivity to teicoplanin. The
35-kDa protein was shown later not to be necessary for
teicoplanin resistance [4], while PBP2 overproduction
seemed to contribute to increased teicoplanin resistance
in S. aureus [1]. Although increased vancomycin resistance
results in increased teicoplanin resistance, the converse is
not always true. In this study we have identi¢ed by genetic
means one of the sites contributing to teicoplanin resis-
tance.
2. Materials and methods
2.1. Bacterial strains and genetic manipulations
The strains used in this study are listed in Table 1. The
strains were grown, where not mentioned otherwise, in LB
medium (Difco, MI, USA) at 37‡C. Transformation of
BB255 was by the CaCl2 method using early exponential
phase cells resuspended in 0.1 M Tris^maleate bu¡er pH
7.5 containing 100 mM CaCl2 as described by Novick [5].
Ten Wg of chromosomal donor DNA in a volume of
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0.1 ml was added to 2 ml of competent cells. After 3 min
in an ice water bath they were incubated for 3 min at
35‡C, centrifuged and resuspended in growth medium
for 1 h. The cells were harvested and resuspended into
saline. Aliquots were plated with a soft agar overlay on
LB plates containing 4 Wg ml31 of teicoplanin. The same
numbers of cells treated with no DNA were used as con-
trols. Transformants appearing after 2 days incubation
were puri¢ed in presence of teicoplanin and analyzed by
replica plating for their resistance pro¢le. One colony with
the highest teicoplanin minimal inhibitory concentration
(MIC) of 16 mg ml31, strain BB938, was kept for further
experiments. Transductions were done with phage 80K [6]
grown on BB938. Transductants were selected with either
10 Wg ml31 of teicoplanin for ¢rst step, or 12 Wg ml31 for
second step transductions, 20 Wg ml31 erythromycin, or
5 Wg ml31 tetracycline. Due to a strong inoculum e¡ect
on teicoplanin, the number of transformed or transduced
cells plated on selective plates and the drug concentration
had to be optimized. The large number of cells (109)
plated on one single plate in transductional crosses re-
quired a selective concentration of 10 Wg ml31 of teicopla-
nin to prevent selection of spontaneous resistant mutants.
2.2. Resistance tests
Antibiotic MIC values were determined by the E-test
method (AB Biodisk, Solna, Sweden) on BHI (Difco)
agar according to the manufacturer’s recommendation.
Antibiotic susceptibility of di¡erent strains was compared
on rectangular LB agar plates containing an antibiotic
gradient. Population analysis pro¢les were made by plat-
ing 0.1-ml aliquots of di¡erent dilutions of overnight cul-
tures grown in BHI on BHI agar containing increasing
concentrations of teicoplanin. The colony forming units
(cfu) were determined after 48 h incubation at 35‡C.
Methicillin was a gift from SmithKline Beecham Pharma-
ceuticals, and Hoechst Marion Roussel AG kindly pro-
vided teicoplanin.
2.3. DNA manipulations
Routine DNA manipulations were done according to
protocols of Sambrook et al. and Maniatis et al. [7,8].
Separation of SmaI-digested chromosomal DNA by
pulsed-¢eld gel electrophoresis was performed as described
by Wada [9]. PCR ampli¢cation of the rsbU gene to iden-
tify the 11-bp deletion in 8325 derivatives was done with
the conditions described earlier [10]. Ampli¢cation of the
rsbW gene region was done with the rsbU-speci¢c forward
primer 5P-CGTGGAAGAATTTAAGCAAC-3P and the
rsbW-speci¢c reverse primer 5P-GCTGATTTCGACTCT-
TTCGC-3P using the PWO polymerase (Roche Biochem-
icals, Rotkreuz, Switzerland). Sequencing with the BigDye
(PE Biosystems) and ABI PRISM 310 Genetic Analyzers
(PE Biosystems) was performed according to the manufac-
turer’s recommendations.
2.4. Western blots
Western blot analysis was performed in accordance with
Sambrook et al. [7], using antigen-puri¢ed polyclonal rab-
bit anti-RsbU and anti-RsbW antibodies (Giachino, P.
and Bischo¡, M., unpublished).
2.5. Peptidoglycan analysis
Extraction of cell walls, amino acid determination of
cell wall material, and analysis of muramidase-digested
peptidoglycan by reversed-phase high performance liquid
chromatography (HPLC) (RP-HPLC) were done as de-
scribed by Roos et al. [11]. Peptidoglycan crosslinking
was calculated from the amounts of muropeptide mono-
mer, dimer, trimer and oligomers in muramidase-digested
cell walls, separated by RP-HPLC, as described by Deze-
lee et al. [12]. To determine the amount of free reducing
termini of muramic acid and glucosamine, the peptidogly-
can was reduced with sodium borohydride and hydro-
lyzed. The reduced and not reduced amino sugars were
submitted to precolumn derivatization with the OPA/
AcOH system (ortho-phthaldialdehyde/N-acetyl-L-cys-
teine). The resulting isoindol derivatives were separated
by RP-HPLC and quanti¢ed by £uorescence detection
[13]. The amount of reduced amino sugar divided by the
total amount of amino sugars gave the percentage of free
termini of the glycan chain [14].
Table 1
S. aureus strains
Strains Relevant genotype or phenotype Origin, remarks
14-4 resistance to methicillin, ampicillin, aminoglycosides, macrolides,
chloramphenicol, tetracycline, and teicoplanin, pigmented colonies
teicoplanin-resistant subclone of the clinical MRSA strain MRGR3
(P. Vaudaux)
BB255 essentially the same as 8325, pig, rsbU, white colonies,
transformable by the CaCl2 method
[6]
BB938 BB255, rsbU, rsbW, resistant to teicoplanin, orange colonies this study, by transformation of BB255 with strain 14-4 DNA and
selection for teicoplanin resistance
PG223 BB938, v(rsbUVW-sigB): :ermB, teicoplanin-susceptible, white
colonies
this study, by transduction of v(rsbUVW-sigB): :ermB from IK181
[10] into BB938
GP274 PG223, (rsbUVW-sigB)-tet, orange colonies, teicoplanin-
resistant
this study, by transduction of (rsbUVW-sigB)-tet from GP267
into PG223 (Giachino, P. and Bischo¡, M., unpublished)
FEMSLE 9726 21-12-00
M. Bischo¡ et al. / FEMS Microbiology Letters 194 (2001) 77^8278
Downloaded from https://academic.oup.com/femsle/article-abstract/194/1/77/484765
by University of Zurich user
on 03 August 2018
3. Results
3.1. Strain construction
The teicoplanin-resistant strain 14-4 was derived from a
multiresistant, initially teicoplanin-susceptible clinical iso-
late MRGR3 [15] which had been passaged in tissue cages
implanted in Wistar rats [16]. Plating of MRGR3 ex vivo
from untreated animals onto selective medium yielded a
few colonies with increased teicoplanin resistance. Serial
passage of bacteria from these colonies on teicoplanin
yielded one mutant strain 14-4 that stably expressed teico-
planin resistance with an MIC of 24 Wg ml31. Strain 14-4
is resistant to multiple antibiotics including methicillin,
macrolides and aminoglycosides, and resistant to trans-
ducing phages. In order to study teicoplanin resistance
in a de¢ned genetic background, the teicoplanin resistance
was transformed from strain 14-4 into the susceptible
strain BB255, which is essentially the same as the genet-
ically well characterized strain NCTC8325, which forms
white colonies due to the pig mutation in the SmaI-I frag-
ment [17]. Selection was for transformants able to grow in
presence of teicoplanin. Mock transformations with no
DNA gave no colonies on teicoplanin agar, but 10 colo-
nies were obtained in the transformation. Most transform-
ants acquired concomitantly with teicoplanin resistance an
intense yellow^orange pigmentation. No other resistance
was transferred. Their teicoplanin MICs ranged from 6 to
24 Wg ml31. One yellow^orange transformant, BB938, with
a teicoplanin MIC of 24 Wg ml31 was selected for further
studies. Strain BB938 had the same teicoplanin resistance
pro¢le in a population analysis as that of the donor 14-4
(Fig. 1). SmaI restriction patterns of the BB255 and
BB938 chromosomes were indistinguishable, but distinct
from that of donor 14-4 showing that BB938 had retained
essentially the BB255 background during transformation.
Teicoplanin resistance of BB938 was increased but vanco-
mycin resistance was very similar to BB255 (Fig. 2).
3.2. Peptidoglycan composition
Isolated cell walls of BB255 and BB938 were indistin-
guishable in amino acid content, sugar composition, and
in the amidation of the iD-glutamate of the peptidoglycan
stem peptide (data not shown). The peptidoglycan compo-
sition corresponded to that of normal S. aureus cell walls
[11]. Similarly, the overall crosslinking of the peptide moi-
ety, 74.4% in BB255, and 74.9% in BB938, showed no
signi¢cant di¡erence. The only di¡erence was an increase
in the length of the glycan chains in the teicoplanin-resis-
tant strain. Strain BB255 showed an average of 34 mono-
saccharide units per glycan chain, while BB938 contained
52 monosaccharide units. Peptidoglycan synthesis results
in glycan chains consisting of repeating units of the dis-
accharide (GlcNAc-(L-1,4)-MurNAc) with reducing termi-
ni in the muramic acid (MurNAc) residues. Reducing ter-
mini containing glucosamine (GlcNAc) are products of a
glucosaminidase [18]. While in BB255 1.4% reducing ter-
mini ending with muramic acid, and 1.5% with glucosam-
ine were found (total amount of 2.9% reduced termini),
the corresponding values in BB938 were 1.6% reducing
termini ending with muramic acid, and only 0.3% ending
with glucosamine (total amount of 1.9% reduced termini).
Reduced termini of glucosamine in S. aureus strains are
usually in the range of 1.4^1.6%, with the exception of
BB938 with only 0.3% reduced termini of glucosamine.
This decrease in glucosamine containing endgroups in
BB938 compared to BB255 may be the result of a lowered
glucosaminidase activity. Moreover, analysis of the peaks
of the RP-HPLC of muramidase-digested peptidoglycan
showed peak areas for peptidoglycan constituents pro-
duced by the autolysins (endopeptidase, amidase and
glucosaminidase) to be 30% lower in BB938 than in
BB255.
Fig. 1. Population analysis pro¢le of recipient, donor, and transductant
on teicoplanin. Squares, strain BB255; empty circles, strain 14-4; ¢lled
circles, strain BB938.
Fig. 2. Growth of strains on plates containing a gradient of teicoplanin
or vancomycin. The corresponding MIC values of teicoplanin or vanco-
mycin are indicated on the right side. An asterisk marks orange pig-
mented strains.
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3.3. Genetic sites involved in teicoplanin resistance
To identify the number of sites involved in teicoplanin
resistance, transducing phage 80K was propagated on
strain BB938 for back-transductions into BB255. We
were unable to transfer the full teicoplanin resistance by
a one-step transduction into BB255. The yellow^orange
pigmentation was found to be 60% cotransducible with
teicoplanin resistance, suggesting that teicoplanin resis-
tance may be located close to the pig locus in strain
BB255, since transducing phages are able to package ap-
proximately 42 kb of DNA [19]. None of transductants
obtained was as resistant as BB938; all had lower teico-
planin MICs ranging between 4 and 8 Wg ml31. Only a
second transduction produced transductants with the orig-
inal resistance of 24 Wg ml31 teicoplanin. The two trans-
duction steps needed to transfer the original teicoplanin
resistance suggested that at least two distinct loci were
responsible for teicoplanin resistance in BB938.
3.4. Pigment production and teicoplanin resistance
It is known that pigment production is dependent on
the activity of the transcription factor SigB encoded in the
chromosomal fragment SmaI-I. Strain BB255 produces
white colonies because of a deletion in rsbU, the ¢rst
gene in the sigB operon rsbUVW-sigB [10]. The possibility
that a mutation in the sigB operon was responsible for the
intense pigment formation in BB938 was investigated as
was the possible coupling to a gene conferring resistance.
The entire sigB operon (Fig. 3C) was deleted in BB938 by
transduction of v(rsbUVW-sigB): :ermB into BB938 with
selection for erythromycin resistance. All transductants
were white and had a lower MIC to teicoplanin, as shown
by the representative transductant PG223 in Fig. 2. The
resistance levels of PG223 were reduced to those of the
¢rst step BB255 transductants obtained earlier. In a fur-
ther transduction, the erm-tagged deletion of PG223 was
replaced by a wild-type sigB operon (rsbUVW-sigB)
coupled to a tet resistance gene derived from the teicopla-
nin-susceptible strain GP267 (Giachino, P. and Bischo¡,
M., unpublished). In the tetracycline-resistant transduc-
tants obtained, pigment production was restored and the
transductants were more resistant to teicoplanin (see
GP274 ^ Fig. 2). This suggested a link between the sigB
operon and teicoplanin resistance. Interestingly the teico-
planin MIC was slightly lower in GP274 (16 Wg ml31) than
for BB938 (16^24 Wg ml31), suggesting that after the two
transductions there were still some di¡erences between
GP274 and BB938.
The RsbU and RsbW gene products of the sigB operon
in strains BB255, 14-4, and BB938 were analyzed by West-
ern blots, with polyclonal anti-RsbU and polyclonal anti-
RsbW antibodies. The unrelated strain Newman [20] was
used as control, and the Western blot revealed RsbU and
RsbW proteins which were also found in the teicoplanin-
resistant strain 14-4. Strain BB255 produced no RsbU as
expected from its rsbU deletion. BB938 was still devoid of
RsbU (Fig. 3A) but had also lost RsbW (Fig. 3B). Loss of
the anti-sigma factor RsbW would leave SigB uncom-
plexed and thus active, which could explain the synthesis
of pigments in BB938.
Ampli¢cation of the DNA region across the 11-bp rsbU
deletion con¢rmed that the 11 bp were deleted in both,
BB255 and BB938 (data not shown). Sequencing of the
chromosomal region of the rsbW gene of BB938 revealed
a point mutation (G2367C, corresponding to accession
number Y07645) within the translated region of rsbW,
which would result in an amino acid substitution (A50P,
corresponding to accession number CAA68931) in the
anti-sigma factor RsbW (Fig. 3C). This mutation was lo-
calized to a region postulated to be essential for sigma
factor interaction [21]. Since no RsbW was detectable in
BB938 (Fig. 3B), although signi¢cant amounts of the
rsbV-rsbW-sigB transcripts were seen in Northern blots
(data not shown), an increased degradation of the mutated
Fig. 3. Western blots of RsbU and RsbW and map of the sigB operon.
(A and B) Ten Wg of cytoplasmic proteins obtained from an overnight
culture were subjected to Western blot analysis. Staining of the proteins
with amido-black prior to antibody incubation con¢rmed equal loading
of the lanes. Strain Newman was used as an unrelated control wild-type
strain. Western blot, (A) with with polyclonal anti-RsbU antibodies;
(B) with polyclonal anti-RsbW antibodies. (C) Map of the sigB operon
[22] and nucleotide and amino acid changes due to the rsbW mutation
in BB938.
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RsbW was postulated. Instability of RsbW may either be
due to misfolding, or to the inability to interact with SigB.
Analogous observations have been made with the closely
related anti-sigma factor SpoIIAB, that was found to be
rapidly degraded when uncomplexed [21].
4. Discussion
Teicoplanin resistance was initially transformed from
14-4 into BB255 yielding a teicoplanin-resistant strain
BB938. None of the other resistance determinants of
14-4 were cotransformed, presumably because they were
located on plasmids or integrated in the mec-associated
DNA in strain 14-4, while the genes a¡ecting teicoplanin
resistance were localized elsewhere on the chromosome.
Full teicoplanin resistance could only be transduced in
two steps, showing that at least two genetic loci were
responsible for the teicoplanin resistance, of which one
cotransduced with the sigB operon. Since the donor
strain had a wild-type sigB operon, but the recipient
BB255, as well as the resulting transformant BB938 had
the 11-bp deletion in rsbU, the rsbW inactivation must
have occurred during the selection of BB938 on teicopla-
nin, and was thus not acquired from 14-4 by transforma-
tion.
A correlation of the sigB operon with teicoplanin resis-
tance became evident through the transduction of the in-
tact sigB operon, from a susceptible donor GP267, result-
ing in an increase in resistance in PG223. Therefore SigB
activity seems to play an important role in developing
teicoplanin resistance. The slight di¡erences in teicoplanin
resistance levels between BB938 and GP274 could be ex-
plained by the fact that, in the former SigB had escaped
anti-sigma factor RsbW interactions and thus was in-
creased in activity, while in the latter SigB activity was
controlled by RsbU, RsbV and RsbW. Alternatively a
further gene contributing to teicoplanin resistance and
mapping close to the sigB operon could not be ruled
out. Such a gene may have been substituted by the wild-
type allele in the transductions leading to PG223 and
GP274. Moreover, the increased pigment content itself
may confer some protective e¡ect against teicoplanin
through capturing of possible reactive agents. These hy-
potheses need to be investigated further. Interestingly, in a
clinical teicoplanin intermediate-resistant isolate [3] a
Tn551 insertion in the SmaI-I fragment increased teicopla-
nin susceptibility and decreased PBP2 production, leading
to the hypothesis that a regulatory DNA fragment was
inactivated.
The increased glycan chain length in BB938 was postu-
lated to be due to a decreased glucosaminidase activity in
these strains. The impact of this observation in relation to
teicoplanin resistance has to be investigated further. A
glucosaminidase activity that modi¢es the S. aureus glycan
structure in vivo has recently been demonstrated [18]. Tei-
coplanin resistance seems thus to be multifactorial, posi-
tively in£uenced by SigB activity, and additive.
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